The Joe Rogan ExperienceJoe Rogan Experience #2134 - Paul Stamets
Joe Rogan and Paul Stamets on paul Stamets Warns of Viral Storms, Champions Mushrooms as Biodefense.
In this episode of The Joe Rogan Experience, featuring Narrator and Paul Stamets, Joe Rogan Experience #2134 - Paul Stamets explores paul Stamets Warns of Viral Storms, Champions Mushrooms as Biodefense Paul Stamets discusses Agarikon, a rare old-growth mushroom he’s spent millions cataloging, arguing that old-growth forests are critical “biodefense libraries” against emerging viral threats like COVID-19 and bird flu.
At a glance
WHAT IT’S REALLY ABOUT
Paul Stamets Warns of Viral Storms, Champions Mushrooms as Biodefense
- Paul Stamets discusses Agarikon, a rare old-growth mushroom he’s spent millions cataloging, arguing that old-growth forests are critical “biodefense libraries” against emerging viral threats like COVID-19 and bird flu.
- He outlines a double‑blind, placebo‑controlled clinical trial where Agarikon and turkey tail mycelium reduced mRNA vaccine side effects and significantly extended antibody levels six months post‑vaccination.
- Stamets and Rogan then explore psilocybin microdosing research, including a large app‑based citizen‑science project showing improved mood, reduced anxiety and depression, and measurable gains in psychomotor performance with the “Stamets stack.”
- They broaden the conversation to psychedelic policy, law enforcement, ancient mushroom use (Egyptian, Mesoamerican, Siberian), AI, and the need to defend biodiversity and cognitive freedom in the face of future “viral storms.”
IDEAS WORTH REMEMBERING
5 ideasProtect old‑growth forests as strategic biodefense assets.
Stamets argues that old‑growth forests house unique fungal strains like Agarikon that have already shown strong antiviral activity against pox, flu, and possibly coronaviruses, making their preservation a national and international security priority.
Agarikon and turkey tail mycelium can reduce mRNA vaccine side effects.
In a double‑blind, placebo‑controlled UC San Diego study, participants taking an Agarikon–turkey tail mycelium blend had dramatically fewer CDC‑listed post‑vaccine adverse symptoms, likely due to upregulation of anti‑inflammatory cytokines IL‑1RA and IL‑10.
Short mushroom dosing may significantly enhance and extend vaccine antibody responses.
The same trial found that just four days of Agarikon–turkey tail around vaccination produced substantially higher antibody levels six months later in COVID‑naive subjects, suggesting a way to improve vaccine efficacy, especially for immunologically depressed individuals.
Microdosing with the Stamets stack shows measurable psychomotor benefits.
Data from thousands of users of the microdose.me app (published in Nature Scientific Reports) showed that people using a stack of low‑dose psilocybin, lion’s mane mycelium, and flushing niacin improved finger‑tapping speed from ~48 to ~68 taps in 10 seconds over 30 days—an objective gain linked to better neural integration.
Psilocybin appears to reliably reduce anxiety and depression for many users.
Across large observational datasets, microdosers report lower anxiety and depression and better mood than non‑microdosers, supporting clinical findings that psilocybin can relieve end‑of‑life anxiety, PTSD, and mood disorders when used in proper settings.
WORDS WORTH SAVING
5 quotesWe should save the old growth forests as a matter of national defense—really, international defense.
— Paul Stamets
With Agarikon and turkey tail, we were able to reduce the adverse effects of mRNA vaccines and at the same time increase antibody responses six months later.
— Paul Stamets
Microdosing is associated with a massive relief of depression, a relief of anxiety, an increase in mood—and now we have objective data on improved psychomotor performance.
— Paul Stamets
Psychedelics is the best potential last hope that we have.
— Joe Rogan
We should all have a civil right to our own consciousness.
— Paul Stamets
QUESTIONS ANSWERED IN THIS EPISODE
5 questionsIf Agarikon and turkey tail can safely enhance vaccine responses and reduce side effects, what would it take to integrate them into mainstream vaccination protocols worldwide?
Paul Stamets discusses Agarikon, a rare old-growth mushroom he’s spent millions cataloging, arguing that old-growth forests are critical “biodefense libraries” against emerging viral threats like COVID-19 and bird flu.
How should governments and conservationists practically value and protect old‑growth forests if they are indeed critical ‘biodefense libraries’ against future pandemics?
He outlines a double‑blind, placebo‑controlled clinical trial where Agarikon and turkey tail mycelium reduced mRNA vaccine side effects and significantly extended antibody levels six months post‑vaccination.
What are the main ethical and safety considerations for scaling psilocybin microdosing and the Stamets stack for cognitive or athletic performance enhancement?
Stamets and Rogan then explore psilocybin microdosing research, including a large app‑based citizen‑science project showing improved mood, reduced anxiety and depression, and measurable gains in psychomotor performance with the “Stamets stack.”
How might law enforcement and healthcare systems change if psilocybin and other natural psychedelics were decriminalized and widely accepted as therapeutic tools?
They broaden the conversation to psychedelic policy, law enforcement, ancient mushroom use (Egyptian, Mesoamerican, Siberian), AI, and the need to defend biodiversity and cognitive freedom in the face of future “viral storms.”
What does the apparent ubiquity of ancient mushroom symbolism—from Egypt to Mesoamerica to Europe—suggest about the historical role of psychedelics in shaping religions and cultures?
EVERY SPOKEN WORD
Install uListen for AI-powered chat & search across the full episode — Get Full Transcript
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome